Michael L. Cher

Also affiliated with The Barbara Ann Karmanos Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer”.

Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer

JAMA Network Open(2021)10.1001/jamanetworkopen.2020.34633

N/A

2.0DataRank · unranked

43 citations

Lance K. Heilbrun, Paul Monk, Sheela Tejwani, Guru Sonpavde, Clara Hwang +10 more

Trials in the Key of G: Building Level 1 Evidence on the Real-world Effectiveness of Prostate Biomarkers

European Urology Focus(2022)10.1016/j.euf.2022.08.001

N/A

0.208DataRank · unranked

3 citations

Anna Harris, Udit Singhal, Michael L. Cher, Daniel E. Spratt, Todd M. Morgan +1 more

Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth

Scientific Reports(2023)10.1038/s41598-023-47633-4

N/A

0DataRank · unranked

8 citations

Diego Sbrissa, Mark Pressprich, Seongho Kim, Arun K. Rishi, Ulka N. Vaishampayan +3 more

Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth

Research Square(2023)10.21203/rs.3.rs-2590830/v1

N/A

0DataRank · unranked

2 citations

Diego Sbrissa, Mark Pressprich, Seongho Kim, Ulka N. Vaishampayan, Michael L. Cher +2 more

Determining the impact of genomic classifier testing on patient-reported quality of life after prostatectomy: Results from the G-MINOR randomized trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.345

N/A

0DataRank · unranked

0 citations

Stephanie Daignault‐Newton, Rodney Dunn, Daniel E. Spratt, Linda A. Okoth, Felix Y. Feng +15 more

A Novel Interaction between Chemokine and Phosphoinositide Signaling in Metastatic Prostate Cancer

Medical Research Archives(2023)10.18103/mra.v11i7.1.4020

N/A

0DataRank · unranked

0 citations

Barani Govindarajan, Michael Wang, Diego Sbrissa, Michael L. Cher, Sreenivasa R. Chinni +1 more

Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover Trial

European Urology(2024)10.1016/j.eururo.2024.09.011

N/A

0DataRank · unranked

8 citations

Stephanie Daignault‐Newton, Daniel E. Spratt, R. Dunn, Udit Singhal, Linda A. Okoth +19 more

Prospective randomized trial of gene expression classifier utility following radical prostatectomy (G-MINOR).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.15

N/A

0DataRank · unranked

6 citations

Linda A. Okoth, Daniel E. Spratt, Rodney L. Dunn, Felix Y. Feng, Anna Johnson +16 more